An approach for identification of highly selective tumor endothelial markers was conducted to develop targeted antiangiogenic immunotherapies.
[Proceedings of The National Academy of Sciences of The United States of America]
Home Newsletters Endothelial Cell News Embryonic Reprogramming of the Tumor Vasculature Reveals Targets for Cancer Therapy
